Radiotherapy Market

Radiotherapy Market Size

The global radiotherapy market was estimated at USD 7 billion in 2023. The market is expected to grow from USD 7.4 billion in 2024 to USD 11.4 billion in 2032, at a CAGR of 5.7% during the forecast period. Radiotherapy is a medical treatment that is used to treat cancer and shrink the tumors by using high dose of radiation, often include radiations such as gamma ray, X-rays, or charged particles that targets and damages the cancerous cell’s DNA preventing them from further cell division and growth. This treatment can be undertaken by two methods, internally through placing radioactive material inside the body near the cancer cell (brachytherapy), or external with the help of instrument known as linear accelerator (external beam radiotherapy).

The growth of the market is highly attributed due to rising prevalence of cancer across the world. For instance, as per the estimates from the Cancer Atlas, the global prevalence of cancer is projected to increase by 60% in 2040, owing to the aging population across the globe, which is equivalent to 29.4 million new cancer cases in 2040 as compared to 18.1 million cancer cases diagnosed in the year 2018. Thus, the rising burden of the cancer, due to the factors such as lifestyle changes, aging population, and environmental factors, fostering the need for advance treatment modalities such as radiotherapy which is evolving as a crucial option to combat various type of cancer. Therefore, as the healthcare providers continuous to adopt these advanced treatment options, the radiotherapy market is anticipated to grow significantly.

Moreover, the rising public awareness pertaining to the various cancer treatment options including radiotherapy is a key catalyst for the growth of the market. Many government organizations and non-profit institutions undertake various awareness programs in order to educate the individuals about the benefits of early disease diagnosis and related treatment options, such cancer immunotherapy, which is estimated to reach USD 277.4 billion by 2032, radiotherapy, among others. For instance, American Cancer Society (ACS) undertake various awareness program throughout the year, such as education pertaining to specific cancer, early detection method, preventive strategies, and various available treatment options and their benefits. Such initiatives accelerate the awareness of early cancer detection and treatment options of various cancer among the individuals, thereby stimulating the adoption of advanced cancer therapies, such as radiotherapy among the healthcare professionals and patients, fostering the market growth.

Radiotherapy Market Trends

• Increasing funding for the healthcare infrastructure, treatments, research and development activities pertaining to cancer is positively influencing the market growth.
  
• For instance, in India under the scheme of Rashtriya Arogya Nidhi (RAN), The Health Minister’s Cancer Patient Fund (HMCPF) provides a financial support of 5 lakh rupees for the patient living below poverty fine and suffering from cancer. Moreover, the maximum upper limit of this aid that is permissible is INR 15 lakh rupees. This scheme is covered across 27 Regional Cancer Centers (RCCs) across the nation.
  
• Thus, such funding from the government organizations stimulates the accessibility of advance treatment options such as radiotherapy among the undeserved population, thus propelling the growth of the market.
  
• Moreover, technological innovations in radiotherapy have significantly accelerated the growth of the market. Advancements such as intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy systems, have enhanced and improved the precision of the treatment by targeting the cancerous cells without effecting the healthy non-cancerous cells. Therefore, this technological enhancement is fostering the adoption of the radiotherapy as a preferred choice of treatment among the patients suffering from cancer.
  

Radiotherapy Market Analysis

Based on type, the radiotherapy market is segmented into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. Furthermore, the external beam radiation therapy segment is further sub-segmented into intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy, and other external beam radiation therapies. The global radiotherapy market was estimated at USD 7 billion in 2023. The external beam radiation therapy segment held revenues of USD 4.6 billion in the year 2023 and the segment is poised for significant growth at a CAGR of 5.6% during the forecast period.

• The rising prevalence of cancer especially the localized cancer such as breast, prostate, lung, colon, among other types of cancer is a key catalyst for the growth of this segment.
  
• For instance, as per the 2022 report of Global Cancer Observatory, lung cancer was the most common type of cancer worldwide with 2.5 million cases followed by breast cancer with 2.3 million cases, then colorectal cancer with 1.9 million cases, prostate cancer with 1.5 million cases, and stomach cancer with 970,000 cases.
  
• Thus, this rising prevalence of various type cancer highlighting the need for effective treatment options such as external beam radiation therapy, accelerating the segmental growth.
  
• Moreover, the technology advancement in proton therapy a type of external beam radiation therapy is further pushing the segmental growth in the forward direction.
  
• For instance, Varian’s ProBeam system which utilize advance technologies such as Pencil Beam Scanning (PBS) and Intensity Modulated Proton Therapy (IMPT), is designed for advanced photon therapy. This system is well known for its precision and have the ability to adapt to complex tumor geometries, such technological advancement is driving the market growth of the segment.
  

Based on application, the radiotherapy market is segmented into lung cancer, prostate cancer, breast cancer, cervical cancer, head and neck cancer, and other applications. The breast cancer segment dominated the market and was valued at USD 2 billion in 2023 with the revenue share of 28.8%.

• The rising prevalence of the breast cancer is one of the key catalysts for the growth of the segment.
  
• For instance, as per the data from the World Health Organization (WHO), in 2022, around 2.3 million women were diagnosed with breast cancer and approximately 670,000 died due to the breast cancer globally.
  
• Moreover, according to the data from the American Cancer Society, in U.S. it is projected that in 2025 around 316,950 women will be diagnosed from the invasive breast cancer, about 59,080 women will be diagnosed with ductal carcinoma in situ and approximately 42,170 women will die due to the breast cancer across the nation.
  
• Thus, as the diagnosis rate of breast cancer increases so does the need for effective treatment such as radiotherapy will increase, thereby propelling the market growth.
  

Based on end use, the radiotherapy market is segmented into hospitals, radiotherapy centers and ambulatory surgery centers, and cancer research institutes. The hospitals segment held the largest revenue of USD 2.9 billion in 2023.

• The growth of the segment is highly attributed due to availability of cutting-edge technologies in the hospital pertaining to the radiotherapy, such as linear accelerator, proton therapy systems, among others.
  
• Moreover, hospital is a one stop destination for various cancer therapies such as the chemotherapy, immunotherapy, surgeries such as tumor resection making this healthcare setting as one of the most preferred options for the treatment of cancer among the patients.
  
• Additionally, hospitals collaborate with the manufactures to develop technological advanced radiotherapy system, further solidifying their position in the fast-pacing market.
  
• For instance, in 2024, the Mayo Clinic and Varian Medical Systems collaborated in order to enhance their radiotherapy abilities. This partnership was intended to enhance Varian’s radiotherapy technology to improve the treatment efficacy, reduce the side effect, and to propel the better patient outcomes. Therefore, collectively all these factors stimulating the growth of the hospital segment in the radiotherapy market.
  

The North America radiotherapy market is forecasted to reach USD 4.1 billion by 2032. The U.S. dominated the North America radiotherapy market with the largest revenue of USD 2.4 billion in 2023.

• The growing prevalence of the cancer in the U.S. in the key catalyst for the growth of the market in the U.S.
  
• For instance, as per the data from the American Cancer Society in 2025, around 2,041,910 new cases of cancer are to be diagnosed and 618,120 cases of cancer related deaths is projected to occur in the U.S.
  
• Thus, the rising prevalence of cancer in the country, is anticipated to stimulate the adoption of advanced treatment option such radiotherapy, boosting the market growth.
  

Europe: The radiotherapy market in UK is expected to experience significant and promising growth from 2024 to 2032.

• The increasing investments from the UK government for improving the cancer infrastructure, training programs pertaining to the advanced devices and systems such as radiotherapy systems, and investment in modern equipment integrated with AI and machine learning is propelling the growth of the market in the country.
  
• For instance, in February 2025, the UK government announced the investment of 82.6 million pounds for integrating the AI technology in cancer treatment and diagnosis.
  
• Thus, such investment is stimulating the advancement of the cancer treatment and diagnosis, fostering the adoption of these innovative technology among the healthcare professionals, propelling the market growth in the country.
  

Asia Pacific: Japan radiotherapy market is anticipated to witness lucrative growth between 2024 – 2032.

• The country as one of speediest aging population. The individuals of this demographic are highly prone to age related chronic diseases such cancer, thereby increasing the need for oncology treatment such as radiotherapy among them.
  
• For example, in 2023 projections from the World Economic Forum revealed that 1 in 10 people in Japan are aged 80 years and above which is about one-third of the population.
  
• Thus, as the population ages in the country so does the chances of cancer, thereby fostering the market growth in the country.
  

Middle East and Africa: The radiotherapy market in Saudi Arabia is expected to experience significant and promising growth from 2024 to 2032.

• The countries government, through their various initiatives such as Vision 2030, expanding the adoptions of various cutting-edge technologies including the innovative technologies pertaining to the cancer treatment such as radiotherapy.
  
• Additionally, the country is prioritizing the establishment of specialized cancer treatment centers and launching public awareness campaigns to promote cancer prevention and early detection. These efforts are stimulating the demand for radiotherapy services in the country.
  

Radiotherapy Market Share

The top 5 players of the radiotherapy market account for approximately 80.5% of the market share which includes companies such as Varian Medical Systems, Elekta, Curium, Accuray, and IBA Radiopharma Solutions. A crucial aspect of market strategy involves the frequent introduction of innovations such as proton therapy, intensity-modulated radiation therapy (IMRT), image-guided radiotherapy (IGRT), among others. Moreover, key industry players command considerable influence in this dynamic landscape, often propelling forward advancements through substantial investments in research and development. Additionally, strategic agreements, acquisitions, and mergers are involved in strengthening the market positions and expanding global footprint along with the evolving regulatory landscapes.

Radiotherapy Market Companies

Some of the eminent market participants operating in the radiotherapy industry include:

• Accuray
• Brainlab
• Curium
• Canon Medical Systems
• Elekta
• Hitachi High-Tech
• IBA Radiopharma Solutions
• Isoray Inc.
• Mevion Medical Systems
• Mitsubishi Electric
• Nordion
• NTP Radioisotopes
• RefleXion
• Toshiba Energy Systems and Solutions
• Varian Medical Systems
  
• Varian Medical Systems has a strong global presence with 70 locations worldwide, and a workforce of 11,000 employees as per the company website.
  
• Elekta has a strong financial position; the company had reported a total revenue of USD 1,699.1 million for the financial year 2023 - 2024.
  

Radiotherapy Industry News:

• In April 2024, GE Healthcare's subsidiary, MIM Software, deepened its collaboration with Elekta AB, aiming to enhance their radiation therapy software. This move expanded on an earlier agreement where GE Healthcare and Elekta primarily worked on supplying imaging and radiation therapy tools to hospitals.
  
• In May 2024, Elekta AB announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent portfolio. This strategic acquisition strengthened Elekta’s position in treatment planning and reinforced its commitment to leading innovation in the field of radiation therapy.
  

The radiotherapy market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• External beam radiation therapy
  • Intensity-modulated radiation therapy (IMRT)
  • Image-guided radiation therapy (IGRT)
  • Proton therapy
  • Other external radiation therapies 
• Internal radiation therapy
• Systemic radiation therapy

Market, By Application

• Lung cancer
• Prostate cancer
• Breast cancer
• Cervical cancer
• Head and neck cancer
• Other applications

Market, By End Use

• Hospitals
• Radiotherapy centers and ambulatory surgery centers
• Cancer research institutes

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada 
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia 
• Latin America 
  • Brazil
  • Mexico 
• Middle East and Africa
  • South Africa
  • Saudi Arabia